This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: The University of Bath, University of Michigan. Active years: 2014.
Company Filing History:
1 out of 51 
1 out of 3,519 
Years Active: 2014
Title: John Traynor: Innovator in RGS Protein Inhibition
Introduction
John Traynor is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of biochemistry, particularly in the development of small molecule inhibitors of RGS proteins. His work has implications for various disease states, including diabetes, epilepsy, neuropathic pain, and depression.
Latest Patents
Traynor holds a patent for "Small molecule inhibitors of RGS proteins." This invention relates to compositions that exhibit RGS (regulator of G-protein Signaling) inhibiting activity. The methods of use for these compositions are particularly relevant in research and treatment of various diseases.
Career Highlights
Throughout his career, John Traynor has been associated with prestigious institutions such as the University of Michigan and the University of Bath. His work has been instrumental in advancing the understanding of RGS proteins and their role in disease mechanisms.
Collaborations
Traynor has collaborated with notable colleagues, including Richard Neubig and Levi Lynn Blazer. Their combined expertise has contributed to the advancement of research in the field of G-protein signaling.
Conclusion
John Traynor's innovative work in the area of RGS protein inhibition showcases his commitment to addressing complex health issues through scientific research. His contributions continue to influence the landscape of biochemistry and therapeutic development.